New benzylidenethiazolidinediones as antibacterial agents

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 21, 2003, Pages 3771-3773

  Heerding, Dirk A ^a   Christmann, Lisa T ^a   Clark, Tammy J ^a   Holmes, David J ^a   Rittenhouse, Stephen F ^a   Takata, Dennis T ^a   Venslavsky, Joseph W ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIINFECTIVE AGENT; BENZYLIDENE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0141656374     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.07.010     Document Type: Article

References (13)

1. Bush K., Macielag M. Curr. Opin. Chem. Biol. 4:2000;433.
2. Bax R., Mullan N., Verhoef J. Int. J. Antimicrob. Agents. 16:2000;51.
3. Wendler P.A., Silverman J.A. Curr. Opin. in Anti-Infective Invest. Drugs. 2:2000;125.
4. Holmes D.J., Throup J.P., Wallis N.G., Burnham M.K.R., Zalacain M., Biswas S., Chalker A.F., Ingraham K.A., Marra A., Bryant A., Woodnutt G., Warren P.V., Brown J.R., Rosenberg M. Focus Biotechnol. 1:2001;23.
5. The cytotoxicity of the compounds was evaluated by measuring cell viability in a human type II lung cell line (A549 cells). Cell viability was colorimetrically estimated by measuring the metabolism of XTT to its formazan derivative.
6. Dess D.B., Martin J.C. J. Am. Chem. Soc. 113:1991;7277.
7. Paternotte I., Fan H.J., Screve P., Claesen M., Tulkens P.M., Sonveaux E. Bioorg. Med. Chem. 9:2001;493.
8. 6 cfu/mL) was added to each well. Inoculated plates were incubated at 35 C for 24 h. Minimum inhibitory concentration (MIC)=the lowest concentration of compound that inhibited visible growth.
9. Barrett J.F. Curr. Opin. Investig. Drugs. 2:2001;212.
10. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S., Renau T., Leger R., Hecker S., Watkins W., Hoshino K., Ishida H., Lee V.J. Antimicrob. Agents Chemother. 45:2001;105.
11. Tashima T., Kagechika H., Tsuji M., Fukasawa H., Kawachi E., Hashimoto Y., Shudo K. Chem. Pharm. Bull. 45:1997;1805.
12. Henke B.R., Blanchard S.G., Brackeen M.F., Brown K.K., Cobb J.E., Collins L., Harrington W.W. Jr., Hashim M.A., Hull-Ryde E.A., Kaldor I., Kliewer A., Lake D.H., Leesnitzer L.M., Lehmann J.M., Lenhard J.M., Orband-Miller L.A., Miller J.F., Mook R.A., Noble S.A., Oliver W., Parks D.J., Plunket K.D., Szewczyk J.R., Willson T.M. J. Med. Chem. 41:1998;5020.
13. Buckle D.R., Cantello B.C.C., Cawthorne M.A., Coyle P.J., Dean D.K., Faller A., Haigh D., Hindley R.M., Jefcott L.J., Lister C.A., Pinto I.L., Rami H.K., Smith D.G., Smith S.A. Bioorg. Med. Chem. Lett. 6:1996;2121.